Takeda Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Co., Ltd./ JP3463000004 /
TKPHF
|
07/11/2024 15:30:00
|
Var.
-1.8400
|
Volume |
Denaro- |
Lettera- |
Capitalizzazione di mercato |
Dividend Y. |
Rapporto P/E |
|
26.7600USD
|
-6.43%
|
119,689
Fatturato: 7,599.8400 |
-Quantità in denaro: - |
-Quantità in lettera: - |
43.47 bill.USD |
- |
- |
Descrizione business
Located in Osaka, Japan, Takeda (TYO: 4502) is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for people worldwide through leading innovation in medicine.
Consiglio di amministrazione & Consiglio di sorveglianza
| CEO |
| Christophe Weber |
| Consiglio di amministrazione |
| Costa Saroukos, Akiko Amakawa, Elaine Shannon, Gabriele Ricci, Giles Platford, Julie Kim, Lauren Duprey, Marcello Agosti, Milano Furuta, Mwana Lugogo, Ramona Sequeira, Takako Ohyabu, Teresa Bitetti, Thomas Wozniewski, Yoshihiro Nakagawa |
| Consiglio di sorveglianza |
| Christophe Weber, Costa Saroukos, Dr. Andrew Plump, Emiko Higashi, Ian Clark, Jean-Luc Butel, Koji Hatsukawa, Michel Orsinger, Olivier Bohuon, Yoshiaki Fujimori, Masami Iijima, Steven Gillis, John Maraganore, Miki Tsusaka, Kimberly A. Reed |
Dati aziendali
| Name: |
Takeda Pharmaceutical Company Ltd. |
| Indirizzo: |
1-1, Nihonbashi-Honcho 2-Chome,Chuo-ku, Tokyo 103-8668, Japan |
| Telefono: |
+81-3-3278-2306 |
| Fax: |
+81-3-3278-2268 |
| E-mail: |
-
|
| Internet: |
www.takeda.com/ |
| Industria: |
Healthcare |
| Settore: |
Pharmaceutical Industry |
| Sub settore: |
Pharmaceuticals |
| Fine dell'anno finanziario: |
31/03 |
| Flottante libero: |
- |
| Data dell'IPO: |
- |
Rapporti con gli investitori
| Name: |
Christopher O'Reilly |
| IR telefono: |
+81-3-3278-2037 |
| IR Fax: |
+81-3-3278-2741 |
| IR e-mail: |
takeda.ir.contact@takeda.com
|
